Regions – Page 57 – pharmaceutical daily

June 22, 2020 Off

Piramal Pharma buys solid oral dosage drug product facility in Sellersville, Pennsylvania from G&W Laboratories Inc.

Piramal Enterprises Limited’s (PEL) Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), has entered into an agreement with G&W Laboratories Inc. to acquire its solid oral dosage drug product manufacturing facility located in Sellersville, Pennsylvania. The transaction closure is subject to customary preclosing conditions.

June 22, 2020 Off

Clinerion’s Patient Network Explorer offers clinical trial performance data for sites in its global site network

By Dino Mustafić

Clinerion’s Patient Network Explorer adds new, actionable functionality to support clinical trial sponsors during site selection as a result of Clinerion’s collaboration with LongTaal, a clinical trial informatics company.

June 17, 2020 Off

Actinium Pharmaceuticals in pricing of $25.0 Million public offering

By Dino Mustafić

Actinium Pharmaceuticals on Wednesday announced the pricing of its previously announced public offering with gross proceeds expected to be approximately $25.0 million.

June 17, 2020 Off

AVEO Announces Pricing of $44.6 Million Public Offering of Common Stock

By BusinessWire

Aveo expects the gross proceeds from the offering to be approximately $44.6 million.

June 17, 2020 Off

Merck and Pfizer’s SGLT2 Inhibitor STEGLATROTM (ertugliflozin) Meets Primary Endpoint in VERTIS CV Trial for Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

By BusinessWire

Results Presented at the American Diabetes Association’s Virtual 80th Scientific Sessions KENILWORTH, N.J. & NEW YORK–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK),…

June 16, 2020 Off

Sanofi invests in vaccine production in France, €490 million over five-years

By Dino Mustafić

Sanofi on Tuesday detailed plans investing in France to increase its vaccines research and production capacities, and contribute in responding to future pandemic risks, aligned with its corporate strategy presented last December, Sanofi will invest €610 million to create a new production site and research center in France with both dedicated to vaccines.

June 16, 2020 Off

TILT Biotherapeutics Secures Over EUR 6 million to Advance Cancer Immunotherapies Into Clinic

By BusinessWire

Tilt Biotherapeutics has secured an additional EUR 6.2m, including EUR 4.5m equity, to advance its proprietary, best-in-class cytokine armed oncolytic adenovirus, TILT-123, into Phase 1 clinical trials

June 16, 2020 Off

Dr. Reddy’s Laboratories Limited announces filing of Annual Report on Form 20-F

By BusinessWire

HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that its Annual Report on Form…

June 15, 2020 Off

German Federal Government invests €300 Million in CureVac

By Dino Mustafić

The Federal Republic of Germany will invest 300 million Euros in the biopharmaceutical company CureVac AG, a pioneer in the preclinical and clinical development of mRNA-based drugs.

June 15, 2020 Off

Hikma, Sun Pharma in licensing agreement for Ilumya for the MENA region

By Dino Mustafić

Hikma Pharmaceuticals and a wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd. (Sun Pharma), the world’s fourth largest specialty generic pharmaceutical company, announced today that they have entered into an exclusive licensing and distribution agreement for Ilumya, an innovative biologic product, for the Middle East and North Africa (MENA) region.